Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2638999012 | Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2642978015 | Codeine phosphate+pseudoephedrine hydrochloride+triprolidine hydrochloride 10mg/30mg/1.25mg liquid | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3084847010 | Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2859101000052116 | kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Is a | kodeinfosfatpreparat | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Codeine phosphate | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Morphinan opioid (substance) | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Codeine (substance) | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Is a | kodeinfosfat + pseudoefedrinhydroklorid + triprolidinhydroklorid | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Triprolidine hydrochloride | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has active ingredient | Pseudoephedrine hydrochloride | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Has manufactured dose form | oral vätska | false | Inferred relationship | Some | ||
| kodeinfosfat 10 mg + pseudoefedrinhydroklorid 30 mg+ triprolidinhydroklorid 1,25 mg, vätska | Is a | Codeine-containing product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR